60 Degrees Pharmaceuticals, Inc.
SXTP
$2.93
-$0.08-2.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 76.50% | 17.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 76.50% | 17.82% | |||
| Cost of Revenue | -197.66% | -66.98% | |||
| Gross Profit | 242.61% | 70.46% | |||
| SG&A Expenses | 32.10% | 7.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.11% | -47.46% | |||
| Operating Income | 2.02% | 49.42% | |||
| Income Before Tax | 5.13% | 48.24% | |||
| Income Tax Expenses | -266.67% | -25.00% | |||
| Earnings from Continuing Operations | 5.17% | 48.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 457.14% | -53.33% | |||
| Net Income | 5.32% | 48.24% | |||
| EBIT | 2.02% | 49.42% | |||
| EBITDA | 2.10% | 49.64% | |||
| EPS Basic | 51.13% | 77.96% | |||
| Normalized Basic EPS | 51.62% | 78.50% | |||
| EPS Diluted | 51.13% | 77.96% | |||
| Normalized Diluted EPS | 51.62% | 78.50% | |||
| Average Basic Shares Outstanding | 95.62% | 140.69% | |||
| Average Diluted Shares Outstanding | 95.62% | 140.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||